QC evaluation

From: ruth ann croson lowney (rcroson@nybc.org)
Date: Fri Jan 09 1998 - 14:40:03 EST

Next message: Nicholas Terry: "Cell Prolif Soc Annual Meeting"
Previous message: Michael G. Ormerod: "Mithramycin protocl on Epics XL"
Next in thread: ruth ann croson lowney: "QC evaluation"
Maybe reply: ruth ann croson lowney: "QC evaluation"
Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]

I am interested in getting a consenus on what clinical labs are doing
concerning lab normals and/or standards.  Specifically, are LJ data being
assessed weekly, monthly etc.; are commercial standards being used ie CD
Chex or Cytorol?  What rules are labs using for lot to lot evaluation of
anitbodies?  Are they using commercial products, and what kind of
acceptance criteria is being used?  Statisically what is acceptable in
determining lab ranges for QC purposes?

I will post a summary when I get the results.

Thanks.

*******************************************************************
Ruth A. Croson-Lowney
Supervisor, Flow Cytometry
New York Blood Center
310 East 67th Street
New York, NY 10021
(212) 570-3341
rcroson@nybc.org

Next message: Nicholas Terry: "Cell Prolif Soc Annual Meeting"
Previous message: Michael G. Ormerod: "Mithramycin protocl on Epics XL"
Next in thread: ruth ann croson lowney: "QC evaluation"
Maybe reply: ruth ann croson lowney: "QC evaluation"
Messages sorted by: [ date ] [ thread ] [ subject ] [ author ]

This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:51:39 EST